Key Details
Annual ROE
-124.76%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 16, 2023Recent annual earnings:
Mar 28, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
20 Mar '23 TD Cowen
Market Perform20 Mar '23 Credit Suisse
Neutral20 Mar '23 Chardan Capital
Neutral16 Nov '22 Citigroup
Buy15 Nov '22 Credit Suisse
Outperform15 Nov '22 Chardan Capital
Buy12 Aug '22 Chardan Capital
Buy12 Aug '22 BTIG
Buy26 July '22 Credit Suisse
Outperform24 June '22 BTIG
BuyScreeners with PEAR included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Pear Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Why Is Pear Therapeutics (PEAR) Stock Down 26% Today?
PEAR
InvestorPlace14 April 2023
Pear Therapeutics (NASDAQ: PEAR ) stock is falling on Friday after the company's recent bankruptcy filing continues to weigh on its shares. Pear Therapeutics announced its bankruptcy filing while markets were closed for Black Friday.
FAQ
- What is the primary business of Pear Therapeutics?
- What is the ticker symbol for Pear Therapeutics?
- Does Pear Therapeutics pay dividends?
- What sector is Pear Therapeutics in?
- What industry is Pear Therapeutics in?
- What country is Pear Therapeutics based in?
- When did Pear Therapeutics go public?
- Is Pear Therapeutics in the S&P 500?
- Is Pear Therapeutics in the NASDAQ 100?
- Is Pear Therapeutics in the Dow Jones?
- When was Pear Therapeutics's last earnings report?
- When does Pear Therapeutics report earnings?
- Should I buy Pear Therapeutics stock now?
What is the primary business of Pear Therapeutics?
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastroenterology, cardiology, and oncology. Pear Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. On April 7, 2023, Pear Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
What is the ticker symbol for Pear Therapeutics?
The ticker symbol for Pear Therapeutics is NASDAQ:PEAR
Does Pear Therapeutics pay dividends?
No, Pear Therapeutics does not pay dividends
What sector is Pear Therapeutics in?
Pear Therapeutics is in the Healthcare sector
What industry is Pear Therapeutics in?
Pear Therapeutics is in the Health Information Services industry
What country is Pear Therapeutics based in?
Pear Therapeutics is headquartered in United States
When did Pear Therapeutics go public?
Pear Therapeutics's initial public offering (IPO) was on 31 March 2021
Is Pear Therapeutics in the S&P 500?
No, Pear Therapeutics is not included in the S&P 500 index
Is Pear Therapeutics in the NASDAQ 100?
No, Pear Therapeutics is not included in the NASDAQ 100 index
Is Pear Therapeutics in the Dow Jones?
No, Pear Therapeutics is not included in the Dow Jones index
When was Pear Therapeutics's last earnings report?
Pear Therapeutics's most recent earnings report was on 16 May 2023
When does Pear Therapeutics report earnings?
The date for Pear Therapeutics's next earnings report has not been announced yet
Should I buy Pear Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions